Skip to content

Modius Spero

by Neurovalens Limited

De Novo DEN250013

Modius Spero is a medical device (FDA Class II; FDA product code SHX) made by Neurovalens Limited, granted FDA De Novo DEN250013 on 8 May 2026, active as of 22 Oct 2026.

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA De Novo, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN250013 Date8 May 2026DecidedStatusActive

Official records

From the FDA record

Received by the FDA
16 Apr 2025
FDA decision
8 May 2026
FDA review time
387 days from receipt to decision

From the FDA De Novo record DEN250013 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA product code
SHX
Device class
Class II
Regulation
21 CFR Part 882.5807
Advisory committee
Neurology
FDA decision
DENG De Novo granted

Other devices from Neurovalens Limited

  • Modius Calm MA1500

    Class II
  • Modius Sleep MS1000

    Class II
  • Modius Stress

    Class II
  • Modius Lean

    Class I